Elizabeth A. Mallon

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

Mitch Dowsett, Jack Cuzick, Christopher Wale et al. · Journal of Clinical Oncology · 2010 · 729 citations

Medicine, Biostatistics, Oncology +17

Evaluating <i>HER2</i> amplification and overexpression in breast cancer

John M.S. Bartlett, James J. Going, Elizabeth A. Mallon et al. · The Journal of Pathology · 2001 · 246 citations

Medicine, Cancer Biology, Oncology +14

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

John M.S. Bartlett, Cassandra Brookes, Tammy Robson et al. · Journal of Clinical Oncology · 2011 · 198 citations · Full text

Medicine, Oncology, Pathology +17

Molecular Drivers of Onco<i>type</i> DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

Richard Buus, Ivana Šestak, Ralf Kronenwett et al. · Journal of Clinical Oncology · 2020 · 119 citations · Full text

Medicine, Genetics, Oncology +14

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer

Melanie Spears, Karen J. Taylor, Alison F. Munro et al. · Breast Cancer Research and Treatment · 2011 · 70 citations

Medicine, Molecular Biology, Oncology +11